Skip to main content
. 2021 Jun 21;8:684920. doi: 10.3389/fcvm.2021.684920

Figure 2.

Figure 2

Platelet released activation biomarkers in arterial and venous cardiovascular diseases determined by ELISA-based tests. AIS, acute ischemic stroke; AMI, acute myocardial infarction; beta-tg, β-thromboglobulin; CAD, coronary artery disease; CD40L, CD40 ligand; CLEC-2, C-type lectin-like receptor 2; GP, glycoprotein; PF4, platelet factor 4; SDF-1α, stromal cell-derived factor-1α; TxA2, thromboxane A2; TxB2, thromboxane B2; PAD, peripheral artery disease; s, soluble; ↑, increased compared to healthy controls; ↓, decreased compared to healthy controls; =, unchanged compared to healthy controls.